Vanda Pharmaceuticals Inc.
VNDA
$5.25
-$0.08-1.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -274.85M | -239.55M | -220.47M | -84.20M | -66.94M |
| Total Depreciation and Amortization | 15.15M | 14.33M | 13.63M | 11.41M | 11.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.18M | 96.37M | 89.09M | -15.05M | -13.67M |
| Change in Net Operating Assets | 12.20M | 2.34M | 8.31M | 6.00M | 4.49M |
| Cash from Operations | -142.33M | -126.51M | -109.44M | -81.84M | -64.80M |
| Capital Expenditure | -674.00K | -783.00K | -998.00K | -1.11M | -1.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.95M | 71.98M | 95.86M | 55.10M | 45.79M |
| Cash from Investing | 120.27M | 71.19M | 94.86M | 53.99M | 44.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.79M | -2.36M | -1.99M | -1.51M | -989.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | -915.00K | -915.00K | -915.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.79M | -2.36M | -2.91M | -2.42M | -1.90M |
| Foreign Exchange rate Adjustments | -253.00K | -83.00K | 23.00K | -199.00K | 49.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.10M | -57.76M | -17.47M | -30.48M | -21.97M |